Neptune Announces the Election of its Directors and Change of Fiscal Year End
Marketwired - Fri Jul 15, 9:37AM CDT
MONTREAL, QUEBEC--(Marketwired - Jul 15, 2016) - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation"
NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01)
Neptune Announces First Quarter Results
Marketwire Canada - Mon Jul 11, 4:31PM CDT
Record Revenues and EBITDA for the Quarter in the Nutraceutical Segment
NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01)
Neptune Announces Fourth Quarter and Fiscal Year Results
Marketwire Canada - Wed May 25, 4:01PM CDT
Positive Forward Momentum Continues
NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01)
Acasti Announces Fourth Quarter and Fiscal Year Results
Marketwire Canada - Wed May 25, 4:01PM CDT
LAVAL, QUEBEC--(Marketwired - May 25, 2016) - Acasti Pharma Inc. ("Acasti" or the "Corporation"
ACST: 1.55 (unch), NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01), APO.VN: 2.090 (-0.010)
Neptune to Hold Conference Call to Discuss Fourth Quarter and Year-End Results
Marketwire Canada - Fri May 13, 7:01AM CDT
LAVAL, QUEBEC--(Marketwired - May 13, 2016) - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company"
NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01)
Jan D'Alvise Appointed President & CEO of Acasti Pharma
Marketwire Canada - Thu May 12, 7:09AM CDT
Seasoned Executive in Drug Development
ACST: 1.55 (unch), NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01), APO.VN: 2.090 (-0.010)
Neptune Announces Term Loan Financing
Marketwired - Wed Apr 20, 10:15AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company"
NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01)
Neptune Announces Preliminary Q4 Results
Marketwired - Tue Apr 05, 6:31AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company"
ACST: 1.55 (unch), NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01)
Nasdaq Grants Acasti Cure Period to Regain Compliance with Audit Committee Membership Requirements
Marketwire Canada - Fri Mar 25, 1:03PM CDT
Acasti Pharma Inc. ("Acasti" or the "Corporation"
ACST: 1.55 (unch), NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01), APO.VN: 2.090 (-0.010)
Acasti Announces Share-for-Debt
Marketwire Canada - Fri Feb 05, 4:30PM CST
Acasti Pharma Inc. ("Acasti" or the "Corporation"
ACST: 1.55 (unch), NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01), APO.VN: 2.090 (-0.010)
Neptune Acquires Biodroga, Creating New Growth Platform
GlobeNewswire - Thu Jan 07, 6:07PM CST
-- Acquires privately held Biodroga, a leading turnkey dietary supplement solution provider with TTM revenues of $22M CDN
NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01)
Neptune to Hold Conference Call to Discuss Third Quarter Results
GlobeNewswire - Tue Jan 05, 6:50AM CST
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation"
NTB.TO: 1.43 (+0.02), NEPT: 1.08 (-0.01)